Rockville's ABL, with CRO and CMO capabilities, is part of a team awarded an IDIQ contract by the U.S. Army MRMC potentially worth $900M. The company also was awarded a 3-Year program extension as the Biologics Production Facility for NHLBI's SMARTT program.
Baltimore startup Tissue Analytics raises $1.9M to further development of its wound care mobile app which enables doctors better analyze wounds and track their recovery.
Columbia's Osiris Therapeutics' first prospective post-market study demonstrates positive clinical outcomes using Grafix in the management of chronic complex diabetic foot ulcers.
Baltimore's Intralytix receives USDA NIFA Phase II SBIR grant to develop a phage-based application to protect hatchery-raised oysters from bacterial pathogens.
Gaithersburg's Smithers Avanza expands its bioanalytical laboratory increasing its staff and space capacity in support of its clients' requests for testing large molecule biotherapeutics.
Baltimore's Profectus BioSciences forms a global collaboration with Vyrid to develop oncolytic recombinant VSV (rVSV) vaccines for cancer immunotherapy.
Frederick biomanufacturing company BioFactura, recently graduated from Frederick Innovative Technology Center (FITC) and moved into a new 5,520 sq. ft. HQ facility with plans to hire 25 new employees during next four years.
The Institute for Bioscience and Biotechnology Research (IBBR) located on the University of Maryland's Shady Grove campus, is seeking proposals to lease a 9100 square foot bio-manufacturing facility configured to produce biologicals under cGMP conditions in compliance with FDA requirements for phase I/II clinical trials.
Baltimore's Key Tech, on a short turn around, successfully developed a one-handed elecrtomechanical inject for use in marketing demonstrations by BD.
Johns Hopkins University's student startup PathoVax continues to make progress and receive recognition for its work developing a broad-spectrum HPV vaccine.
The deadline to apply for TEDCO's new Life Science Investment Fund is April 15th.
This is the last week to join AdvaMed, BioHealth Innovation, the City of Frederick, Frederick County, MaxCyte, MdBio, Novavax, Montgomery College, Pii, REDI, TCM, and UMB as booth exhibitors in the Maryland pavilion at BIO2016, June 6-9, in San Francisco. Additional opportunities for visibility in the pavilion will be announced next week. Contact the MD Department of Commerce for more information.
Are you a biotech or health IT company developing new products? Don't miss the opportunity to list your company in the 2016 MD BioHealth Directory (due to space limitations this is for R&D co's only). Contact MD Department of Commerce by April 5th to be included.
The MD Dept. of Commerce has market research resources--Frost and Sullivan, Recap, Medtrack and BioMedTracker--available to Maryland-based biohealth entrepreneurs at its offices in Baltimore and Rockville. Please schedule appointments in advance.
|
|
Upcoming Deadlines and Events
|
Epigenomics (Germantown)
To view more job opportunities,
Omnia Biologics (Rockville) please check at the
bottom of the MD COMMERCE
Osiris Therapeutics (Columbia) BioHealth and Life Sciences website. |
|
FLAVORx CEO Stu Amos unveils company's new automated medicine flavoring system* with support from MD Commerce Secretary Mike Gill and Howard County Exec. Allan Kittleman.
|
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.
The Department's Office of BioHealth and Life Sciences supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies. These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, data center services, patient engagement, and wellness.
|
|
|
|
